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In recent years there has been increasing debate about the impact of scaled-up ART and PMTCT 
programmes on the uptake and outcomes of reproductive health services, in particular the potential 
detrimental effects of HIV-care on the overall capacity of fragile health systems. The objective of this study 
was to evaluate changes in the uptake of reproductive health services as well as the main pregnancy 
outcomes during the scaling up of ART and PMTCT in Thyolo District, Malawi.  
Methods 
Study design: retrospective descriptive district-wide cohort analysis for the period 2005 to 2009. 
Setting: Thyolo District, an area with around 600,000 inhabitants, an adult HIV-prevalence of 21% and a 
Total Fertility Rate of 5.7 in 2004. HIV-care including ART and PMTCT was scaled up since 2004 in Thyolo 
District to reach district-wide coverage in 2007. HIV-care is provided at district hospital, health centre and 
community health post levels.  
Outcomes: uptake of antenatal, intrapartum and postpartum care, family planning and treatment of 
sexually transmitted infections; infrastructural changes, and changes in maternal and perinatal pregnancy 
outcome. 
Data collection and analysis: data were collected from facility antenatal, intrapartum and postpartum 
records, as well as from MoH and MSF databases maintained for routine programme monitoring. Chi-
square tests were performed comparing the baseline year (2005) with the year of study end (2009).  
Results 
Uptake of peripartum care had improved markedly by the end of the five-year study period: the 











30%, 25% and 20% respectively. The number of family planning consultations increased by almost 50% and 
the number of women treated for sexually transmitted infections more than doubled. 
Interactions between HIV-care and general reproductive health care had positive effects on key health 
system components, including governance, health financing, human resources and drug supply. 
Reliable pregnancy outcome indicators for the entire observation period were difficult to obtain due to 
likely under-reporting of facility-based maternal and perinatal mortality. However, previously documented 
results from Thyolo show a reduction of facility-based severe maternal complications, including uterine 
rupture, between 2007 and 2009. 
Conclusions 
Uptake of reproductive health services and facility-based maternal outcomes increased markedly during 
the period of HIV scale–up. This implies that the scale up of HIV-care did not inhibit, and likely increased, 
uptake of reproductive health services, while quality improvements in perinatal care could still be 
successfully implemented. The finding that ART and PMTCT care may be successfully integrated into 
broader reproductive health services with satisfying outcomes is a strong argument for continued scale up 













The impact of HIV on health systems 
In sub-Saharan Africa, the burden of HIV illness, and the scaling up of programmes to prevent and treat 
HIV/AIDS, have had a considerable impact on the health systems of most countries (Chopra et al. 2009; 
Lawn et al. 2008). During the last 30 years, HIV/AIDS has transformed the burden of disease throughout the 
region (UNAIDS & WHO 2005). Public health systems that were already under-resourced to cope with 
existing health demands have struggled to provide adequate care to a growing influx of patients with AIDS-
related opportunistic infections (Chopra et al. 2009); many patients presented with pathologies that had 
been uncommon before (such as cryptococcal meningitis or Kaposi’s sarcoma) putting the ability of health 
systems to deal with these diseases to an additional test (Lawn et al. 2008).  
At the same time as HIV increased the demand on health systems, it also reduced the ability of the health 
system to cope as health workers themselves were affected, both directly through increased HIV-related 
morbidity and mortality, and indirectly through increased burnout (Bemelmans et al. 2011; Yu et al. 2008). 
The increase in HIV-related patient burden led to a decline in the performance of health services including 
services for non-HIV-related illness (Samb et al. 2010; Yu et al. 2008). In other words, HIV exposed the 
inability of under-resourced public health systems to provide basic preventive and curative care, and this 
has been suggested to have contributed to an increase in maternal and infant mortality (Buve et al. 2003; 
Yu et al. 2008). 
In the early 1990s, studies from Western countries showed that antiretroviral therapy (ART) and prevention 
of mother-to-child transmission (PMTCT) had the potential to dramatically reduce HIV-related mortality, 
including maternal mortality, and paediatric HIV-infection (Blower et al. 2000; Kim & Gilks 2005; Peckham & 
Gibb 1995). However, concerns about the feasibility of implementing large-scale HIV-programmes in low-











full support from national governments and international donors until late 2003 (Kim & Gilks 2005). 
Initially, the scaling-up of ART and PMTCT services often occurred through specific vertical programmes 
that operated independently from the general health system.  
The impact of HIV-programmes on reproductive health services 
A comprehensive definition of reproductive health services includes antenatal, intrapartum and
postpartum services as well as treatment of sexually transmitted infections (STIs) and family planning
services (WHO 2010a). Several authors have expressed concerns about the potential negative effects of 
vertical HIV-programmes on reproductive health services and their outcomes (Both & Van Roosmalen 2010;
Chopra et al. 2009; Hanefeld 2010; Hanefeld & Musheke 2009; Magoma et al. 2010). Concerns include: (1)
the diversion of funding away from reproductive health towards HIV (Both & Van Roosmalen 2010; Chopra
et al. 2009; Yu et al. 2008), (2) the hypothesis that scaled-up HIV-testing could reduce uptake of general
reproductive health services due to HIV-related stigma (Simba et al. 2010; Turan et al. 2008), and (3) the
demands on the scarce health workforce posed by these rapidly expanding HIV-programmes (Banteyerga et
al. 2006; Nuwagaba-Biribonwoha et al. 2007).
However, the actual impact of these potentially negative effects on reproductive health has not been
comprehensively studied or documented (Both & Van Roosmalen 2010; Brugha et al. 2010). In particular,
changes in uptake and outcomes of reproductive health services within well-integrated ART/PMTCT-
programmes remain unclear (Both & Van Roosmalen 2010; Kennedy et al. 2010). In the absence of
documented programmatic evidence confirming or refuting these concerns, the scepticism about the
benefits of large-scale HIV-programmes remains. This scepticism, in turn, has contributed to decreased
political and financial support for ART and PMTCT, ultimately putting hard-won public health gains at risk 











ART and PMTCT-programmes in Malawi 
Malawi is one of the countries most heavily affected by the HIV-pandemic. The HIV-prevalence rate among 
adults from 15 to 49 years of age was 12% in 2007 (UNAIDS 2009) with young women disproportionately 
affected compared to their male counterparts: the HIV-prevalence in women aged 15 to 24 years was 9% in 
2010, versus 2% among men in the same age group (USAID 2010). Despite a severe lack of financial and 
human resources in the country’s health sector, Malawi managed to scale up access to ART with marked 
success. By the end of 2009 at least  271,105 people had started ART, of whom 198 846 (73%) were alive 
and on treatment (MoH HIV department 2009). This represented almost two-thirds of the need for ART (30, 
000 people) at the time (MoH 2008b). This coverage figure compares favourably with Malawi’s better-
resourced neighbour South Africa, where ART coverage in 2009 stood at less than 40% (Adam & Johnson 
2009). This difference reflects the difference in political will between both states: the Malawian 
government relatively quickly acknowledged the scale of the HIV-epidemic and the need for action 
(Kachapila 1998), whereas the South African president and minister of health supported an AIDS-denialist 
position until as late as 2008, casting doubt on the link between HIV and AIDS and hampering the scaling up 
of ART and PMTCT (Cohen 2000). 
The achievements of the Malawi ART programme came after a period in which there had been no 
significant improvement in the uptake of other general health services including perinatal care. Despite 
efforts to promote antenatal care (ANC) attendance, the uptake of ANC services, for instance, did not 
improve between 2000 and 2004: only around 50% of all pregnant women met the recommended number 
of four or more antenatal visits, a mere 8% had received ANC during the first trimester of pregnancy, and 
around 10% had not accessed ANC at all (National Statistical Office 2005).   
The low ANC-attendance was one reason why the scaling up of quality PMTCT programmes in Malawi 
turned out to be more challenging compared to the ART rollout. Other reasons for the delay in PMTCT 
scale-up include: (1) the inadequate link between general maternal and child health (MCH) services and 











high drop-out rates of women entering into the PMTCT-programme due to the effects of stigma as well as 
financial and logistical constraints for women to access care (Bwirire et al. 2008; Manzi et al. 2005) and (3) 
an insufficiency of health workers to support MCH and PMTCT service delivery (Nakakeeto & Umaranayake 
2009).  
By June 2010, out of 8944 HIV-positive women in Malawi who attended ANC during the second quarter of 
2010, 6345 (71%) received antiretroviral prophylaxis. This represented 35% PMTCT coverage among the 
estimated 18,210 HIV-positive pregnant women in the country during that quarter (MoH 2010). The 
majority of ART and PMTCT services is delivered within the public health system by government clinicians 
and nurses (Bemelmans et al. 2010). 
In Thyolo, a rural district in southern Malawi, Médecins Sans Frontières (MSF) and the Ministry of Health 
(MoH) embarked on a district-wide scale-up of ART and PMTCT between 2003 and 2007 (Bemelmans et al. 
2010). Between 2007 and 2010, ART and PMTCT were increasingly integrated into general health services, 
meaning that ART and PMTCT care were provided, wherever possible, at the same clinics, during the same 
hours, and by the same staff as general (peripartum) care. During the process of service integration, uptake 
of ART was maintained at steady levels and access to PMTCT further increased (Bemelmans et al. 2010). 
This study examined changes in reproductive health services and outcomes in Thyolo District during the 
phases of scaling up and integrating HIV care into general health services. The intention was to evaluate 
whether the scaling up of ART and PMTCT had been detrimental to the uptake and outcomes of 














This chapter presents a review of the literature related to HIV, ART, PMTCT and reproductive health. 
 
Search strategy 
A search of the Cochrane library was conducted to target systematic reviews related to ‘HIV’, ‘antiretroviral 
therapy’ and ‘prevention of mother-to-child transmission’. In addition, a search of the Medline electronic 
database using the PubMed-interface was conducted using the following terms: ‘HIV’ AND ‘ART’ AND 
‘review’, ‘HIV’ AND ‘prevention of mother-to-child transmission’ AND ‘revie ’, ‘HIV’ AND ‘reproductive 
health’ AND ‘health systems’, limiting the search to articles written in the English language and published in 
the highest-impact journals according to the Thomson Reuters Citation Index (Thomson Reuters 2011). In 
addition, an internet-search was conducted via the conference proceedings of international AIDS 
conferences, and Google scholar, to search for the most relevant reports and court hearings about the civil 
society movement for access to HIV-care. 
HIV and antiretroviral therapy 
In 1981, the clinical syndrome of the Acquired Immune Deficiency Syndrome (AIDS) was first reported 
(Gottlieb et al. 1981) and in 1983, HIV was cultured and established as the causative agent of AIDS (Barre-
Sinoussi et al. 1983). When diagnostic tests became available, the enormous scale of the HIV epidemic 
became clear (Volberding & Deeks 2010). By end-2008, more than 33 million people were projected to be 
living with HIV worldwide, two-thirds of whom residing in sub-Saharan Africa (UNAIDS & WHO 2005).  
HIV-infection follows sexual or parenteral exposure to HIV-containing fluids, and targets CCR5 CD4 memory 
T-lymphocytes (‘CD4 cells’). Initial HIV-infection may be accompanied by flu-like symptoms after which the 
infected person enters an asymptomatic phase of varying duration, lasting between a few months and 











classic AIDS-defining events such as Pneumocystis jirovecii pneumonia or cryptococcal meningitis occur 
when the count drops below 200 cells per µl and immunity is severely compromised. However, some 
serious complications, such as Kaposi’s sarcoma or tuberculosis –the most common opportunistic infection 
in sub-Saharan Africa– may also occur at higher CD4 counts (Volberding & Deeks 2010). 
If no treatment is given, HIV-infection will almost inevitably lead to death of the infected person. The 
median survival from onset of AIDS is around 9 months in sub-Saharan Africa (Morgan et al. 1997). 
However, ART – usually a combination of three different drugs – can suppress the virus and regenerate CD4 
count levels. ART drugs are classified according to which step in the viral life cycle they inhibit. Nucleoside 
analogues (e.g. zidovudine, lamivudine, stavudine and tenofovir) and non-nucleoside reverse transcriptase 
inhibitors (efavirenz, nevirapine) are the most common classes used in low-income countries because 
generic formulations are available at relatively low cost and often as fixed dose combinations (Volberding & 
Deeks 2010). 
Despite a longstanding high demand for ART in low-income, high-prevalence countries such as Malawi, ART 
drugs were until recently inaccessibly expensive due to price-protecting patents held by Western 
pharmaceutical companies (Achmat & Simcock 2007; Heywood 2001; Waning et al. 2010). Therefore, 
although ART had become available in more affluent settings during the 1990s, the most heavily affected 
populations in low-income countries had no access to any form of this life-saving treatment (UNAIDS & 
WHO 2005).  
Around the turn of the millennium, several civil society groups across the globe started questioning this 
injustice and claiming the right to antiretroviral medication (Achmat 2002a). In particular, the South African 
Treatment Action Campaign provided a crucial political and legal voice to people living with HIV and AIDS in 
Southern Africa. The Campaign sued the South African government for not providing PMTCT (Achmat 
2002b), while at the same time supporting them in a case brought up by pharmaceutical industries trying to 











(Heywood 2001) and became one of the landmark cases that help promote the right of governments to 
access affordable sources of cheap generic antiretroviral medicines. Similar struggles were taking place in 
other developing countries, including Brazil, Guatemala, India, Kenya and Thailand (Achmat & Simcock 
2007; Ford 2003; Ford et al. 2007).  
Despite the successes of civil society groups, it still took considerable time before governments began to
scale up ART services (Waning et al. 2010). In most countries, including Malawi, this scale-up depended on
access to some of the cheaper drugs, most notably Stavudine and to a lesser extent Nevirapine, that had
long been replaced in more affluent settings because of their toxicity. Stavudine is commonly associated
with neuropathy and lipodystrophy, and may even cause life-threatening lactic acidosis (WHO 2010d). 
WHO now recommends that countries move away from Stavudine-containing regimens to Tenofovir- and
Zidovudine- containing treatment (WHO 2009). Due to cost implications, this has not yet happened in
Malawi, nor in many other countries (MoH 2008a).
Following WHO guidelines, eligibility for ART in Malawi and in many other low-income countries is
established based on either clinical criteria using the WHO staging system or immunological criteria using a 
CD4 cell count (MoH 2008a). The staging system was developed with the objective of facilitating ART scale-
up in a simplified manner, supportive of a public health approach (WHO 2005): all individuals classified with
stage 3 disease (e.g. pulmonary tuberculosis, oral candidiasis) or stage 4 disease (e.g. Kaposi’s sarcoma, 
cryptococcal meningitis) should be started on ART regardless of CD4-count, those in stage 1 (asymptomatic) 
or stage 2 (mild disease) require a CD4-count to determine eligibility for ART (WHO 2009). The optimum
CD4 threshold for starting ART is still subject to scientific debate (Volberding & Deeks 2010). WHO currently
recommends that treatment is started at a CD4 count below 350 cells per µl, although the threshold in












 (Prevention of) mother-to-child transmission of HIV 
In the absence of any preventive intervention, 14-23% of the HIV-positive pregnant women in non-
breastfeeding (western) populations will transmit HIV to their infants, while in breastfeeding populations 
this mother-to-child-transmission (MTCT) rate is 25-48%. The risk of MTCT is independently associated with 
maternal viral load, mode of delivery, and gestational age (Sturt et al. 2010).  
MTCT may occur at any of three time-points:  
(1) in utero: HIV is thought to infect the placenta directly and may either spread cell-to-cell or pass into 
the foetal circulation with maternal mononuclear cells (Sturt et al. 2010);  
(2) intrapartum: through contact between neonatal skin and mucosa with cervicovaginal secretions 
and blood; longer duration of rupture of membranes increases the risk of transmission (by 
approximately 2% per hour); microtransfusions during the first stage of labour may also play a role 
(Sturt et al. 2010); 
(3) during the breastfeeding period: associated factors include duration of breastfeeding, maternal 
viral load and CD4 count, breast anomalies, younger maternal age and higher parity (Horvath et al. 
2009; Nicoll et al. 1995; Richardson et al. 2003; Sturt et al. 2010; WHO 2010d). 
Suggested interventions to prevent maternal-to-child transmission include: 
(1) delivery by caesarean section: however, there is no benefit of this intervention when the maternal 
viral load is low, and complications of operative delivery, especially in low-resource settings, 
outweigh any possible benefit (Sturt et al. 2010); 
(2) cessation of breastfeeding: this not a practical option in most low-income countries, as no 
affordable and safe feeding alternatives are usually available. The WHO now recommends to 











(3) antiretroviral prophylaxis by mono- [Zidovudine (AZT) or Nevirapine (NVP)], dual (AZT and NVP, but 
no additional benefit), or triple drug regimens (recommended by WHO for all pregnant women 
with CD4 counts below 350 cells per µl also because of their own health) (WHO 2010c);   
(4) NVP-prophylaxis to the infant throughout breastfeeding, combined with maternal antiretroviral 
prophylaxis during pregnancy: a regimen under consideration in many countries since it recently 
became an option recommended by WHO for women with CD4 counts above 350 cells per µl 
(‘Option A’), as an alternative to continuing maternal triple-therapy throughout breastfeeding 
(‘Option B’) (WHO 2010c); 
A number of other interventions have been proposed, including vaginal disinfection, vitamin A 
supplementation and hyperimmune HIV-immunoglobulin, but none have shown any clear benefit (Sturt et 
al. 2010). 
WHO promotes a four-pronged approach to PMTCT with these components: (1) primary prevention of HIV-
infection among women of childbearing age; (2) preventing unintended pregnancies among women living 
with HIV; (3) preventing HIV-infection from these women to their infants and (4) providing appropriate 
treatment, care and support to mothers living with HIV and their children and families (WHO 2010e). 
In sub-Saharan Africa the percentage of pregnant women tested for HIV has increased from 6% in 2004 to 
28% in 2008, largely due to provider-initiated testing. During the same period the percentage of HIV-
positive pregnant women receiving antiretrovirals to prevent mother-to-child transmission increased from 
9% in 2004 to 45% in 2008 (WHO 2010e). 
In order to build on this progress made, seven strategic directions have been put forward by WHO:  
(1) strengthening commitment and leadership from partners at global, national and regional levels,  
(2) providing technical guidance,  
(3) promoting and supporting integration (with reproductive health programmes),  











(5) supporting health systems interventions,  
(6) measuring of programme performance and impact and  
(7) collaborating at global, national and local level. Since sub-Saharan countries not only bear the highest 
HIV-burden but also the greatest challenges to making progress in maternal and child health, integration 
with reproductive health services is proposed in order to promote equitable and universal access to 
primary health care (WHO 2010e). 
Reproductive health: definitions, outcome indicators and trends 
WHO provides a comprehensive definition of reproductive health: ‘Within the framework of WHO's 
definition of health as a state of complete physical, mental and social well-being, and not merely the 
absence of disease or infirmity, reproductive health addresses the reproductive processes, functions and 
system at all stages of life. Reproductive health, therefore, implies that people are able to have a 
responsible, satisfying and safe sex life and that they have the capability to reproduce and the freedom to 
decide if, when and how often to do so. Implicit in this are the right of men and women to be informed of 
and to have access to safe, effective, affordable and acceptable methods of fertility regulation of their 
choice, and the right of access to appropriate health care services that will enable women to go safely 
through pregnancy and childbirth and provide couples with the best chance of having a healthy infant’ 
(WHO 2010a, p 1). 
Based on this definition, the following types of services provided within the Malawian health system are 
considered to provide a comprehensive overview of available reproductive health services: antenatal, 
intrapartum and postpartum services, treatment of sexually transmitted infections (STIs) and family 
planning services. 
The most commonly applied outcome indicators for the quality of antenatal, intrapartum and postpartum 
care are facility-based maternal mortality, severe acute maternal morbidity and perinatal mortality 











common definition of maternal mortality, and that applied throughout this study, is: ‘the death of a woman 
while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from 
accidental or incidental causes’ (WHO, 2007b, p 1238). For perinatal mortality, the WHO definition is 
applied throughout this study: ‘the death of a child during the period between the 24th week of gestation 
and the end of the first week of life (including stillbirths)’ (WHO, 2010b, p 1). No universal definition exists 
for severe acute maternal morbidity. In under-resourced settings disease-specific morbidity criteria are 
most commonly applied because these are the most convenient (Gulmezoglu et al. 2004b). The following 
conditions are commonly included: (severe pre-) eclampsia, major obstetric haemorrhage (peripartum 
blood loss of more than one litre), severe peripartum infection, uterine rupture and/or obstructed labour 
(Gulmezoglu et al. 2004; Oladapo et al. 2005; van den Akker et al. 2011; van den Akker et al. 2009; Zwart et 
al. 2008). 
In 2000, the United Nations ratified the Millennium Development Goals (MDGs) that set targets for 
decreasing  maternal mortality by three-quarters and under-five mortality by two-thirds by 2015, compared 
to the 1990 levels (United Nations 2011). After a marked increase in maternal mortality between 1990 and 
2000, possibly as a result of the HIV-epidemic (Bicego et al. 2002; Hogan et al. 2010), the maternal 
mortality figures in Malawi appear to show some improvement since the millennium ratification, possibly 
as a result of ART-scale-up (Hogan et al. 2010; Mayosi et al. 2009). However, the country-wide maternal 
mortality ratio remains a devastating 1140 per 100,000 live births in 2008 (compared to 743 per 100,000 in 
1990) (Hogan et al. 2010). Malawi appears to be on track to meet the target for under-five mortality; 
however, progress was slow for neonatal mortality (death within the first 28 days of life; from 42 to 27 per 
1000 live births between 1990 and 2004) (Bhutta et al. 2010), indicating that access to safe perinatal care 
remains problematic.  
Since around half of the deliveries in Malawi occur outside the formal health sector, general community-











services. Facility-based figures are more suitable, but often absent or unreliable (Bhutta et al. 2010; 
Kongnyuy et al. 2009a; Kongnyuy et al. 2009b). Depending on the criteria are used for maternal morbidity, 
there are between 5 and 223 severe acute maternal morbidities for every maternal death (Say et al. 2004). 
Severe acute maternal morbidity is increasingly applied as an additional indicator for the quality of 
perinatal health care (Gulmezoglu et al. 2004; Mantel et al. 1998; Say et al. 2004; Zwart et al. 2008).  
In South Africa alone, sexually transmitted infections (STIs) account for 26% of all deaths and for the loss of 
over five million disability-adjusted life years in 2000. Of this burden of disease, 98% was due to HIV/AIDS 
(Johnson et al. 2007). The HIV and conventional STI epidemics are interdependent: similar behaviours, such 
as frequent unprotected intercourse with multiple partners, place people at high risk of both types of 
infection, and conventional STIs increase the likelihood of HIV transmission (Sangani et al. 2004). According 
to WHO estimates, around 340 new cases of syphilis, gonorrhoea, chlamydia and trichomoniasis occurred 
in 1999 worldwide (WHO 2001).  
Family planning has been a neglected part of health care provision in Malawi, for political and social 
reasons (Kirk & Pillet 1998; Lema et al. 1998). Public discourse about contraception was long considered 
unchaste, particularly during the autocratic Banda-reign (Yeatman & Trinitapoli 2008). Women are often 
not empowered to take independent decisions regarding if and when to become pregnant (National 
Statistical Office 2005). In recent years, access to family planning has become a more prominent issue for 
politicians and health managers (Meekers et al. 2007). Most modern contraceptive methods are now 
available in the public sector (National Statistical Office 2005; van den Akker & Lommerse 2010). Probably 
as a result of the liberalization of family planning, the unmet need for family planning declined from 36% in 
1992 to 28% in 2004, while the total demand and percentage of demand satisfied increased from 26% to 
55% between 1992 and 2004. The national total fertility rate decreased slightly between 2000 and 2004 











Effects of HIV programmes on reproductive health outcomes and services
A number of authors have highlighted the positive effects of ART/PMTCT programmes on the quality of
general reproductive health services, describing positive outcomes such as a reduction in maternal
mortality (Evjen-Olsen et al. 2009), increased syphilis testing among pregnant women (Potter et al. 2008)
and improvements in the general quality of antenatal care (Delvaux et al. 2008). Others, however, have
described negative effects on quality of care such as a decrease in motivation of health workers due to a
higher workload (Nuwagaba-Biribonwoha et al. 2007) and more prolonged labours due to the reluctance to
artificially rupture membranes to enhance delivery resulting from an often unjustified fear of increasing
HIV-transmission (Nuwagaba-Biribonwoha et al. 2007). 
A systematic analysis of the quality of reproductive health care in settings with high PMTCT/ART-coverage 
has not been performed as noted previously by others (Both & Van Roosmalen 2010; Kennedy et al. 2010). 
Several authors have argued that PMTCT policies have historically had too narrow a focus on the health of
the child, and then primarily on HIV-specific outcomes, while underestimating the role of PMTCT in
contributing to maternal health (Ginsburg et al. 2007; McIntyre 2005).
With regard to the uptake of services, several authors have hypothesized that HIV-services could prohibit
women from accessing general pe ipartum care. Threats to uptake include: disruption of peripartum
services due to off-site training courses in ART and PMTCT (Banteyerga et al. 2006), fear among women of 
stigma and discrimination by partners and other relatives when tested HIV-positive at the antenatal clinic
(Simba et al. 2010) and fear of maltreatment by health workers upon testing HIV-positive, negatively
impacting uptake of intrapartum care (Turan et al. 2008). A systematic review found no particular effects
on the uptake of postpartum care, family planning or STI treatment after implementing PMTCT (Both & Van
Roosmalen 2010). 
In the same way that the importance of these possible negative effects on uptake and quality remains 











positive impact of PMTCT and ART care on quality could potentially enhance the uptake of reproductive 
health services and reduce maternal and perinatal mortality within a population, the actual occurrence of 
this effect has not been described. This leads the authors of the same recent systematic review to draw the 
conclusion that, ‘PMTCT programmes miss the opportunity to contribute to the improvement of maternal 
health services’ (Both & Van Roosmalen 2010).  
In short, there is no conclusive programmatic evidence for disadvantages or benefits of ART/PMTCT-care on 
the uptake and outcomes of reproductive health services. The effects of scaled-up HIV-programmes on 
uptake and outcomes of peripartum care, family planning and STI-services remain unclear due to the 
limited availability of scientific reports, particularly from settings where HIV-care has been integrated with 
general reproductive health care (Both & Van Roosmalen 2010; Kennedy et al. 2010).  
However, it is clear that considerable scepticism about the impact of scaled-up HIV-care on reproductive 
health services has characterized the published literature in recent times, leading WHO to stress the need 
for ‘health system strengthening’ alongside or before considering scaling up access to ART and PMTCT 
(Kennedy et al. 2010; WHO 2010c; WHO 2010d; WHO 2010e). 
For a well-functioning health system that may provide both adequate HIV-care as well as general 
reproductive health care the following key components have been suggested to be necessary: governance, 
financing, infrastructure development, procurement and supply chain management, human resources, 
health information systems, service delivery and supervision (Atun et al. 2010; Harries et al. 2009; Harries 
et al. 2010). The interaction between ‘vertical’ disease-specific programmes and ‘horizontal’ health systems 
strengthening takes place at the level of each of these components. Changes in each of these key 
components may have an impact on the health system and on the delivery of HIV-care and reproductive 
health care as a result (Harries et al. 2009; Harries et al. 2010). Therefore, a description of changes in these 
key components caused by the scaling-up of ART/PMTCT-care may contribute to a description of their 











Aims and objectives 
 
Aims: 
A. To describe the most important changes in uptake of reproductive health services and health outcomes 
during the scaling up of PMTCT and ART services; 
B. To assess whether this scaling up has contributed general reproductive health service delivery in Thyolo, 
Malawi in a positive or negative way. 
 
Objectives: 
A. To assess uptake of the following reproductive health services:  
a. antenatal services (with integrated PMTCT services) 
b. intrapartum care  
c. postpartum care 
d. treatment of STIs 
e. family planning services  
B. To assess health system improvements in key components of the health system 
C. To assess changes in pregnancy outcome: maternal mortality, severe acute maternal morbidity (uterine 
rupture, eclampsia, major obstetric haemorrhage defined as a blood loss of more than one litre around the 













This chapter presents the overall research design and methods used in the study. 
Design 
This was a retrospective district-wide programme analysis, or a pre- and post implementation study. This 
type of study design falls under the rubrique of ‘operational research’, in which the data evaluated are 
routinely-collected programme data and the outcomes are directly applicable to the practical programme 
situation (Zachariah et al. 2009; Zachariah et al. 2010). 
Study period 
The study period was from 1 January 2005 to 31 December 2009.  
Setting 
Thyolo District is a rural area in southern Malawi with around 600,000 inhabitants, most of them 
subsistence farmers (National Statistical Office 2005; National Statistical Office 2008). The area has a 
predominantly hilly topography dominated by a number of large tea estates, with only one major tarmac 
road crossing the district.  Access to health facilities is often difficult due to a lack of motorized transport 
and poor road conditions, particularly during the rainy season when the roads become muddy (Van den 
Akker & Lommerse 2010). 
More than two-thirds of the people live in extreme poverty and the literacy rates in 2004 were 62.4% for 
women and 79.3% for men (National Statistical Office 2005). Although health care in government facilities 
and maternal care in most mission facilities are free-of-charge, lack of money for transport is one of the 
barriers negatively impacting on health-seeking behaviour (Blencowe et al. 2009; O'Gorman et al. 2010). 











and discrimination, particularly among young women and girls (National Statistical Office 2005; O'Gorman 
et al. 2010). 
Intervention/programme approach 
Since 2003, MSF and MoH entered into a collaborative partnership to increase and maintain access to ART 
in Thyolo. MSF provided logistical support, technical guidance and limited human resources, while MoH 
provided most of the human resources and additional infrastructure as well as the medication obtained 
through the Global Fund. The scaling up of ART made use of a public health approach, based on task 
shifting, decentralization, standardized treatment and simple programme monitoring. This led to achieving 
the target of district-wide coverage late 2007, with 80% of the estimated need for ART fulfilled (Bemelmans 
et al. 2010). This 80%-target was set by MSF in line with the 80% target established by WHO and UNAIDS to 
define ‘universal access’ to PMTCT and ART (Interagency Task Team 2007; WHO & UNAIDS 2006). At the 
end of June 2010, there were almost 17,000 people alive on ART in Thyolo (MSF 2010). 
The MSF/MoH programme for PMTCT started in 2002 at the district hospital. The medication used was 
single-dose nevirapine (sd NVP) as per WHO recommendation at that time (WHO 2003). In 2007, after the 
WHO-recommendation had changed based on new evidence regarding more effective and safer drug 
interventions (with lower chances of drug resistance) the regimen changed to zidovudine (AZT) from 28 
weeks gestation combined with sd NVP at the onset of labour and a seven day tailing off, as well as AZT-
prophylaxis to the child (WHO 2006). Since 2003, women eligible for ART for their own health have been 
started on a combined regimen consisting of stavudine (d4T)/lamivudine (3TC)/NVP. ART among pregnant 
women in Malawi is established by clinical and immunological evaluation, with (A) all those in WHO clinical 
stages 3 and 4 or (B) all those in stages 1 and 2 AND with a CD4 count below 350 cells/mm3 eligible for ART 
(until March 2010 the threshold stood at 250 cells/mm3) (MoH 2008a; WHO 2006). The newest WHO 
guidelines, which promote more robust and safer ART regimens as well as a continuation of ART-protection 
throughout the breastfeeding period, have not yet been implemented in Malawi but are currently under 











implement improved protocols will depend on the willingness of international donors to provide adequate 
funding (IRIN Plus News 2010).  
Since achieving district-wide coverage of ART and a significant increase in uptake of PMTCT, the focus of 
the Thyolo HIV-programme shifted to the integration of HIV-care within general health services 
(Bemelmans et al., 2010; MSF, 2010).  
Health system 
The health system in Thyolo is comprised of one district hospital (approximately 4,500 deliveries in 2009),
one mission hospital (approximately 1,500 deliveries in 2009), 13 government health centres, seven mission
health centres and five private centres (tea estates). In case of complications requiring emergency hospital
care, transport from health centre to district hospital usually relies on a limited number of hospital
ambulances, but these are poorly maintained and often unreliable. Specialist treatment and intensive care
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Registered nurse-midwives hold a degree in nursing and midwifery from the Malawi College of Nursing. In 
the absence of this highest-trained nursing cadre, nurse-midwife ‘technicians’ generally perform the same 
tasks as registered nurse-midwives although their education is limited to diploma level. Due to a scarcity of 
medical doctors, non-physician clinicians perform most of the clinical work. Medical assistants, who follow 
two years of professional training, are mostly based in health centres and perform non-invasive primary 
care including ART initiations. Clinical officers have four years of professional training and are usually based 
at the district hospital. They perform more advanced clinical care including surgery such as caesarean 
section (National Statistical Office 2005; Van den Akker & Lommerse 2010). 
Antenatal care 
An estimated 28,400 term pregnancies were expected to occur in Thyolo in 2009 (National Statistical Office 
2005; National Statistical Office 2008). ANC protocols in Malawi generally follow WHO recommendations. 
Opt-out HIV testing and counselling takes place upon the first antenatal visit. Four visits are recommended, 
and the first visit should take place in the first trimester of gestation (National Statistical Office 2005). In 
Thyolo, ANC is delivered by nurse-midwife technicians at the district hospital and health centres. Since 
2007, PMTCT has been provided in the general antenatal clinic with the same nurse-midwife (technician) 
providing both general reproductive health and PMTCT care (Van den Akker & Lommerse 2010). 
Intrapartum care 
At facility level, intrapartum care is provided at health centres by nurse-midwife technicians and at the 
district and mission hospitals by nurse-midwife technicians and registered nurse-midwives. At the district 
hospital, clinical officers are available in case of complications requiring invasive intervention such as 
caesarean section. Since 2005, one relief expatriate medical doctor with experience in obstetrics is 











The Malawian government encourages women to deliver at formal health facilities, but still around half of 
the women in Malawi deliver at home, often with the assistance of a Traditional Birth Attendant (TBA) 
(National Statistical Office 2005). Although obstetric care in the public health system is provided free-of-
charge, several barriers discourage women from accessing formal care, including socio-cultural factors, a 
low perceived need-benefit-ratio and physical inaccessibility. One barrier recognized by the MoH and many 
health workers within the Malawian health system was that women were requested to bring a cloth wrap 
for the newborn after delivery. Even though bringing this cloth was not a formal obligation and the MoH 
condemned health workers for insisting on it, some women expressed that they were afraid to come 
without a cloth due to shame or fear. In Thyolo, we hypothesized that providing women with a post-partum 
enhancement package including a baby blanket and a traditional wrap could encourage them to come for 
delivery at a health facility as a culturally-sensitive non-monetary incentive to enhance facility delivery (van 
den Akker et al. 2010).  
Postpartum care 
Postnatal visits are advised at one and six weeks after delivery. The physical and mental states of the 
mother are assessed by taking a short history and performing vital signs measurements and a focused 
physical examination. The infant is weighed and examined and breastfeeding is observed, and appropriate 
feeding advice given accordingly. Postpartum care is provided by nurse-midwife technicians at health 
centre level and by registered nurse midwives at district hospital level. The visit at six weeks should be 
integrated with the provision of family planning services and neonatal care including immunization 
(National Statistical Office 2005; Van den Akker & Lommerse 2010). 
Family planning 
Increasingly, and in accordance with current national policy, contraception is made readily accessible in all 
outpatient departments in Thyolo District, both for HIV-positive and HIV-negative people (MSF 2010; Van 
den Akker & Lommerse 2010). The most commonly applied methods are injectable contraceptives (Depo-











per year since 2005 underwent a bilateral tubal ligation. Intra-uterine contraceptive devices are available 
but rarely used due to cultural beliefs. Contraceptive implants (Norplant®) are used by a minority of mostly 
higher-educated women (e.g. family of health workers).  
Sexually transmitted infections 
In 1992, the Malawi Government adopted the Syndromic Management Approach for the treatment of STIs 
that also forms the basis for STI treatment in Thyolo. This implies that a number of syndromes are treated 
according to guidelines described in easy-to-use flowcharts. These syndromes are: cervical cancer, genital 
ulcer disease, urethral discharge, abnormal vaginal discharge, lower abdominal pain in women, scrotal 
swelling, inguinal bubo, balanitis and neonatal conjunctivitis (WHO 2007). HIV-positive patients in Thyolo 
are actively screened and referred for treatment of these conditions (Van den Akker & Lommerse 2010). 
Although patients are encouraged to bring their sexual partners for STI treatment, active contact tracing is 
not done.  
Health promotion 
All women attending STI care are actively encouraged to have themselves tested for HIV. In turn, all women 
attending HIV-care are supposed to be asked whether they have STI-related complaints and treated if this is 
the case. Women attending HIV-care should be encouraged to use condoms. However, some health 
workers, especially those in catholic mission health centres, have embraced the ‘abstinence-adagio’ and are 
reluctant to offer condoms during consultations. In general, it is a challenge to convince health workers to 
offer more reliable contraceptive measures in addition to condoms. Recently, efforts have been undertaken 
to improve family planning health promotion, in particular to HIV-positive women, as well as the uptake of 
antenatal care, particularly in the first trimester, to all women. Women attending STI treatment and HIV-
care are encouraged to bring their husbands to the clinic during subsequent visits for assessment and 
treatment. Lastly, all client-health worker contacts are supposed to be entry points for HIV-prevention. 
Conventional STI contacts are used to provide health promotion messages on the prevention of STI 













We chose 2005 as the baseline year and 2009 as the outcome year. Outcomes collected were:  
Uptake indicators: 
(1) antenatal uptake data (first visit, four visits, uptake of HIV-testing, PMTCT-uptake) 
(2) uptake of intrapartum care 
(3) uptake of postpartum care (only for the one-week visit, data for the six-week visit are not recorded) 
(4) uptake of STI treatment 
(5) number of family planning visits as a proxy for the uptake of contraceptive measures 
 
Outcome indicators: 
(1) facility-based maternal mortality, perinatal mortality and severe acute maternal morbidity 
(2) PCR-HIV test outcome among children born to PMTCT-mothers 
 
In addition, we described the major changes in the key components of the health system as detailed on 
page 24:  governance, financing, infrastructure development, procurement and supply chain management, 
human resources, health information systems, service delivery and supervision (Atun et al. 2010; Harries et 












Data collection and analysis 
Data sources used per study objective 
In order to achieve objective A (to assess the uptake of reproductive health services) data were collected
from facility-records (MoH, mission and private facilities), the HMIS database and the MSF database
(PMTCT-uptake) maintained for routine programme monitoring. To achieve objective B (to assess health 
system improvements) data were retrieved from the same databases, as well as from the MSF annual 
report in 2010 (MSF 2010), earlier studies conducted in Thyolo (Bemelmans et al. 2011; van den Akker et al.
2009; van den Akker et al. 2011; Jouquet et al. 2009) and from a local situation analysis of maternal and
child health services which was primarily based on MoH-data (van den Akker & Lommerse 2010). To
achieve objective C (to assess pregnancy outcome) data were retrieved from the HMIS, the MSF database 
(PCR-outcome data) and from previous studies (van den Akker et al. 2009; van den Akker et al. 2011).
Background of data sources 
The HMIS database is managed by the district health office and contains data on peripartum care delivery
(uptake of antenatal, intrapartum and postpartum care) and the main pregnancy outcome indicators 
(maternal and perinatal mortality, maternal morbidity). 
Facility-records include information on the uptake of STI care and family planning services. Unfortunately, 
there are no reliable data on repeat visits for family planning or on STI treatment outcome, nor on the 
uptake of treatment among partners of STI patients. Data from facility records were collected by a
dedicated MSF staff member with experience in data collection, and by the family planning and STI 
coordinators from the District Health Office (DHO). All data were crosschecked by senior MSF and DHO
staff. 
The MSF database is managed by experienced staff with a background in epidemiology or information 











regularly performed on both the MSF and the MoH databases by verifying sentinel information contained in 
databases with facility records intermittently.  
In addition to routinely collected clinic data, data were used from the ‘4M-study’ (study of maternal 
mortality and maternal morbidity in Thyolo) that was conducted in the district between September 2007 
and September 2009. The 4M-study had the objective to evaluate the effects of obstetric audit and 
feedback on the occurrence of maternal mortality and severe acute maternal morbidity. All instances of 
maternal mortality and severe acute maternal morbidity were included in this study. In line with several 
other international studies disease-specific criteria were used to define severe acute maternal morbidity 
(Gulmezoglu et al. 2004; Zwart et al. 2008), as these criteria are the most convenient in low-resource 
settings: (1) uterine rupture, (2) eclampsia, (3) major obstetric haemorrhage (estimated blood loss more 
than one litre or two or more units of blood transfused), (4) severe infection that required medical or 
surgical treatment, (5) any other condition that the clinician found severe acute morbidity. 
Data analysis 
From all these sources, data relevant for this study were entered into a separate, password-protected 
Microsoft Excel sheet. Analysis was performed using IBM® SPSS® Statistics version 15 and OpenEpi 
(www.openepi.com) software packages. Two-by-two tables were constructed to compare baseline and 
outcome values for each uptake indicator. For all analyses, a P-value of <0.05 was considered significant. 
 
Ethics 
Permission was obtained from the Faculty of Health Sciences Human Research Ethics Committee of the 
University of Cape Town, South Africa (See Annex A). In addition, this study has met the Medecins Sans 
Frontieres’ Ethics Review Board-approved criteria for analysis of routinely-collected programme data (See 
Annex B). 













The absolute number of people presenting at antenatal, intrapartum and postpartum services all markedly 
improved comparing the beginning (2005) and end (2009) of the observation period. Based on the 
estimated numbers of pregnant women per year, there was a marked increase in the uptake of peripartum 
care. 
Antenatal care 
The number of women who attended at least one antenatal visit increased from 15,655 in 2005, to 25,310 
in 2009. In 2005, there were an estimated 25,052 pregnant women; in 2009 there were projected to be 
28,384 (National Statistical Office 2005; National Statistical Office 2008). This means that the uptake of ANC 
went up from 62.5% in 2005, to 89.2% of pregnant women in 2009 (OR 4.95, 95%CI 4.73-5.18, p<0.001). 
The number of women who attended at least four antenatal visits as recommended by WHO went up from 
3391 in 2008, to 4694 in 2009 (OR 1.41, 95%CI 1.34 – 1.48, p<0.001). The number of HIV-tests performed in 
pregnant women between 2005 and 2010 increased from 4133 to 23,081. There may have been repeat 
tests in the same women throughout the same pregnancy, especially since we started emphasizing re-
testing in 2009. 
In 2005, 936 women received single-dose nevirapine (NVP) for PMTCT, out of an estimated 5260 HIV-
positive pregnant women that year (HIV-prevalence 21%, number of pregnant women 25,050). In 2009, 
2922 women received an improved PMTCT regimen including zidovudine (AZT) from 28 weeks gestation, 
out of an estimated 5960 pregnant women (HIV-prevalence 21%, number of pregnant women 28,380). This 













In the two-year period between late 2007 and late 2009, before and after implementation of the incentive 
that included soap, a baby blanket and a traditional wrap, the number of deliveries in health facilities 
throughout the district almost doubled (van den Akker et al. 2010). In figure 2, the sharp increase in 
deliveries after implementation of the incentive (indicated with an arrow) is visible. 
Postpartum care 
In 2005, 3253 women came for a postnatal visit at around one week after delivery. This number gradually 
increased reaching a peak of 10,470 in 2008, with a slight decline thereafter (for unknown reasons) to 9401 
women in 2009. This represents an increase in the uptake of postpartum care of 20% among pregnant 
women between 2005 and 2009 (OR 3.32, 95% CI 3.18 – 3.47, p<0.001).  
Figure 2 shows the increases in uptake for antepartum, intrapartum and postpartum care between 2005 
and 2009, calculated as women receiving any antepartum, formal intrapartum and postpartum care as 












Figure 2. Increase in uptake of peripartum care between 2005 and 2009. 
 
Treatment of sexually transmitted infections 
Between 2005 and 2009, the number of women receiving treatment for STIs increased from 5345 to 12,117 
(population exposed 140,000 and 150,000 women of reproductive age respectively). This means that the 































Figure 3. Number of women receiving STI treatment. 
Family planning 
The number of family planning consultations at medical facilities in Thyolo district increased from 73,625 in
2005 to 108,427 in 2009, an increase of 47% (Figure 4). This includes consultations in the public as well as
the private sector. While it is not known how many of these consultations were repeat consultations nor
for how many women, it is clear that uptake of modern contraceptive methods shows a marked increase
throughout recent years.
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We follow the key components of the health system where the interaction between ‘vertical’ disease-
specific programmes and ‘horizontal’ health system strengthening takes place (Atun et al. 2010; Harries et 
al. 2009; Harries et al. 2010).  
Governance 
The interaction between the District Health Office and MSF was generally found to increase the 
transparency of the decision-making process. Every year, one larger joint planning meeting and several 
smaller meetings between MSF and MoH health mangers were organized, during which both the priorities 
in HIV-care and those in reproductive health and other general health care services were addressed. The 
difference in administrative years between the government (starting in the middle of the calendar year) 
and MSF (following the calendar year) allowed for the tracking of budgets of each of these groups and 
allocating funds appropriately in order to jointly address priorities. 
Financing 
A costing study for the Thyolo HIV-programme identified ART costs and costs of other essential drugs as the 
main cost driver behind the ART/PMTCT-programme: US$158 out of US$237 annual direct treatment costs 
per patient on ART were spent on medication, and two-thirds of the treatment costs per patient went into 
ART alone. ART has been provided by the Global Fund. Consultation costs contributed only 13% to the total 
annual cost per patient. District-wide ART-coverage was achieved at US$2.5 additional spending per Thyolo 
inhabitant, and was found to lie well within estimated basic health package costs (Jouquet et al. 2009).   
The financial support for the delivery incentive came from MSF, using money from the ART/PMTCT 
programme at a cost of seven US$ per woman. In Thyolo District, with 30,000 deliveries per year, the 
maximum cost if every woman accessed the package, would be US$210,000 per year. This would increase 
the cost of the essential health package by about US$0.3 per head per year, which is affordable in this 












Four maternity waiting homes were built at peripheral health centres throughout the district in 2007 and 
2008. These waiting homes started being used early 2009. Four maternal and child health units of health 
centres were renovated in 2008. These constructions and renovations were all supported with funds from 
MSF’s HIV/AIDS programme budget (MSF 2010; Van den Akker & Lommerse 2010).  
Five facilities were upgraded to provide full Basic Emergency Obstetric Care services, including the 
possibility to perform vacuum extraction, administer magnesium sulphate and intravenous antibiotics and 
perform manual vacuum aspirations. This involved both upgrading of existing buildings and equipment, as 
well as training of health staff. The upgrading was financed by both MoH and MSF, using both general funds 
and HIV-funds. 
Procurement and supply chain management 
In general, effective procurement and supply chain management are major challenges in Malawi, which 
cannot be discussed in detail here. The poor functioning of the procurement system, including the 
functioning of the central medical stores which are responsible for the supply of all drugs in the public 
health system, was a major reason for the Global Fund to reject the country’s national strategic application 
in February 2010 (Nyasa Times 2011). At district level, supply systems of MSF and MoH have been 
integrated into one general procurement and supply system, and combined efforts have been undertaken 
to enhance performance. 
The availability of essential medications within the health system improved thanks to investments in 
second- and third-line antibiotic regimens supported by funding from the HIV/AIDS programme. For 












Human resources  
Despite the launching of an Emergency Human Resource Plan in 2004, the number of health workers did 
not increase much in Thyolo in recent years. The only measurable improvement was at the district hospital 
where the number of hospital clinical officers went up from 11 in April 2007 to 19 in April 2010. However, 
no increases were seen in other cadres or in health centres (Van den Akker & Lommerse 2010). One 
important initiative in the district that has most certainly contributed to increased availability of existing 
health staff was the implementation of a dedicated and confidential staff clinic providing general primary 
care including ART to all staff and their first-degree relatives (Bemelmans et al. 2011).  
Health information systems 
Basic information on MSF and MoH databases was given in the chapter on data collection (page 34). The 
information collection tools for HIV and general reproductive health care still function rather 
independently. A sustainable and comprehensive computerized health information system is not currently 
in place, although the government is currently exploring different systems (Baobab Health Partnership 
2011).  
Service delivery and supervision 
Together with efforts to increase uptake, measures to improve the quality of peripartum care were taken. 
A system of rigorous obstetric audit was implemented and supervision of all delivery rooms by senior staff 
increased (van den Akker et al. 2011; Van den Akker et al. 2009). Supervision of antenatal and postpartum 
services and infrastructure also increased and was performed by a joint team of senior MSF and MoH 
health workers and managers. Audit results are described in the section on maternal and perinatal 














Out of 503 children whose mothers had received PMTCT at any of the peripheral health centres and who 
were tested by Polymerase Chain Reaction (PCR) in 2009, 47 (9.3%) tested positive. The data, 
unfortunately, do not specify at what age the HIV-test was performed. Among 670 children born to 
mothers who had attended PMTCT at the district hospital, 30 (4.5%) were tested HIV-positive. 
The District Health Management Information System (HMIS) reported between 14 and 20 deaths per year 
for the years 2005 to 2009 (Table 1). However, the 4M-study to maternal mortality and morbidity in the 
district conducted between September 2007 and September 2009 counted 29 inclusions for maternal 
mortality alone in the year 2008 (Van den Akker et al. 2009). This suggests that the reliability of the 
maternal mortality data in the HMIS is poor due to under-reporting. 
Reported perinatal deaths varied between 212 in 2007 to 129 in 2009. However, in 2010 (after the study 
period ended), following efforts to improve recording and reporting of perinatal mortality there were 159 
perinatal deaths reported in the first six months only (table 1). This leads us to suspect that data for 
previous years do not reflect true perinatal mortality. Due to these reliability concerns, perinatal mortality 












Table 1. Maternal and perinatal mortality reported at HMIS. Comparison with the 4M-inclusions indicates 
that there is gross underreporting of maternal mortality; the high number of perinatal mortality in 2010 is 
likely to be due to more stringent data collection. 
Data Maternal deaths 
reported to HMIS 
4M-study Perinatal deaths reported to HMIS 
2005 14  N/A 
2006 15  159 
2007 14 8 (September – December 
only) 
212 
2008 20 29 183 
2009 12 9 (January – August only) 129 
2010   159 (January-June only!) 
 
Data for maternal morbidity reported to the district health office before September 2007 were also 
considered unreliable due to substantial underreporting. For instance, only 16 uterine ruptures were 
reported to HMIS for all of 2005, whereas the prospective 4M-study identified 19 ruptures in the first three 
months of the study alone (Van den Akker et al. 2009). We consider that the 4M-study gives accurate 
insight into facility-based maternal mortality and severe acute maternal morbidity between September 
2007 and September 2009. Based on 4M-study results, we were able to document improvements in 
maternal pregnancy outcome for Thyolo District Hospital and other facilities (van den Akker et al. 2011; van 











Over the two years, 386 women with serious complications were included in the study. Among these, 46 
women died and 340 sustained severe acute maternal morbidity (Case Fatality Rate: 11.9%). Forty-five 
cases were audited in plenary; care for 30 cases was assessed to be substandard by more than half of the 
available staff (van den Akker et al. 2011). 
During the first three months of the 4M-study period, a particularly high incidence of uterine rupture of 
almost 20 per 1000 hospital deliveries was observed. This was thought to be due to poor adherence to local 
standards. Therefore, several audit sessions were organized. At the request of hospital staff a larger session 
involving two external obstetricians-gynaecologists was held following which recommendations were put 
forward and implemented, including refresher training (funded by MSF with ‘HIV-funds’), increased on-the-
job coaching and supervision by seniors, and follow-up visits to peripheral centres. The incidence of uterine
rupture decreased by 68% (OR 0.32; 95% CI, 0.16-0.63) to 6.1 per 1000 deliveries over the next 9 months 
(Figure 5). The overall case fatality rate was 11.4%, and the perinatal mortality rate was 829 per 1000 live
births (Van den Akker et al. 2009). Throughout the second year of study, the incidence of uterine rupture











Figure 5. Incidence and type of uterine rupture before and after audit aimed at uterine rupture in Thyolo 
District Hospital (Van den Akker et al. 2009) 
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In addition to this assessment of uterine rupture, the total number of severe acute maternal morbidity and 
mortality cases were analysed during the two-year period in which audit of a variety of mortality and 
morbidity cases was performed. A plot of severe maternal complications (severe acute maternal morbidity 
and mortality) showed a reduction in the number of complications during the two-year study period from 


































Red: uterine ruptures in unscarred uteri 
post-admission; Orange: ruptures in 
scarred uteri post-admission; Yellow: 
ruptures in unscarred uteri pre-
admission. There were no ruptures in 











Figure 6. Regression lines of maternal mortality, morbidity and total complications, calculated per 1000 
health facility deliveries. 
 
 
Individual case reviews showed a particularly high number of maternal infections amongst cases of severe 
acute maternal morbidity and maternal mortality. Maternal infections had replaced haemorrhage, 
traditionally the major cause of poor maternal outcome, as the most common cause of maternal mortality. 
HIV-infection seems to play an important role in this shift: more than 30% of women sustaining severe 
acute maternal morbidity and 40% of women who died were HIV-positive (van den Akker et al. 2011).  
Numerous recommendations resulting from audit were implemented, and many of which were partially 
supported by HIV programme funds. Therefore, although reliable information on facility-based maternal 
and perinatal indicators before 2007 is not available, the 4M-outcome data show that despite marked 
















































system, maternal pregnancy outcome improved. This improvement was most likely a result of simultaneous 
investments into the quality of care using audit and feedback, (refresher) training, increased supervision by 
senior staff, improved infrastructure and investments towards district-wide provision of BEmOC (van den 













Strengths and limitations  
 
This study is based on operational research data from a routine programme review. This approach has 
several strengths and limitations that deserve mentioning.  
The main strength of this approach is that the data are all derived from ‘real programme’ inputs and 
outputs, and as such provide a credible picture for programme planners who are concerned about on-the-
ground inputs and outputs. While randomized trials have the distinct advantage of controlling for potential 
confounding factors in order to allow for a valid and precise estimate of the true effect of a particular 
intervention, the conditions of randomized trials (highly resourced, focusing on a single intervention with 
considerable attention paid to limiting loss to follow up) are very rarely approximated in an operational 
context, particularly a setting such as rural Malawi (Zachariah et al. 2009). 
However, this approach carries with it a number of important limitations. First, we relied on programme 
data that had been routinely collected for programme tracking. Proper recording and storing of data is 
often a challenge in under-resourced settings since it is usually not given high priority (Wagaarachchi et al. 
2001). Maternal morbidity as well as perinatal and mortality mortality all seemed substantially 
underreported at the District Health Management Information System and we had to resort to 
‘independent’ study data for reliable pregnancy outcome indicators. However, all the other data used in 
this analysis for the period 2005 to 2009 are considered reliable for several reasons. First, data reported at 
HMIS and MSF were regularly crosschecked with facility records. Second, data on peripartum care, family 
planning and STI treatment all showed very clear trends without any major ‘outliers’. Finally, all data were 
verified by senior data staff with experience in data collection and monitoring.   
Second, as this study did not attempt to investigate causal relationships but rather a number of programme 











improvements described may have happened despite rather than because of investments in PMTCT and 
ART. However, where possible, this study attempts to show which initiatives were implemented with 
money allocated to HIV, thus allowing for the tentative conclusion that taking HIV funding has broadly 
benefitted the overall health system and contributed tremendously to the reproductive health 
improvements summarized in this report. At the very least these findings show that scaling up PMTCT and 
ART does not necessarily pose a hindrance to improvements in other health priorities. 
The generalizability of these findings to other districts may be limited due to the fact that the scaling-up of 
ART and PMTCT and the investment in reproductive health services in Thyolo received considerable 
support from MSF. Although many districts receive various levels and forms of NGO-support, not all of 
them may have the same means to achieve the positive trends described in this report.  
The data about the uptake of reproductive health services included data from mission and private facilities, 
in addition to government clinics. However, the changes in the key components of the health system were 
largely based on results of the collaboration between MSF and MoH and therefore apply primarily to public 
health facilities and should not automatically be inferred to include mission and private facilities. In fact, 
improvements in these parts of the health system may have lagged behind. 
Although it was previously documented that the uptake of formal delivery care was not larger in mission 
facilities compared to other facilities following the implementation of the enhancement package, the 
signing of service-level-agreements between the DHO and mission facilities may have had some additional 
positive impact on the uptake of care (van den Akker et al. 2011). Other factors that may have contributed 
to the increased uptake of peripartum care include increased investment in community awareness of safe 
peripartum practices by the Ministry of Health and other partners as well as efforts by the government to 
discourage women from delivering with TBAs. These factors may have had some impact on the described 












This is one of the first district-wide studies that attempted to comprehensively describe the effects of the 
PMTCT and ART rollout on general reproductive health service uptake and outcomes. The findings suggest 
that this scale-up, provided that it is planned with the general health system in mind may benefit 
reproductive health in a broader sense, in addition to increasing survival among the HIV-positive and 
reducing vertical transmission.  
Uptake of peripartum care, family planning and STI treatment all improved significantly during the scale-up
of HIV-care in Thyolo. This shows that: (1) the integration of opt-out HIV testing and counselling and PMTCT
care within the general peripartum services did not prohibit more women from accessing care as others 
had feared (Simba et al. 2010; Turan et al. 2008), (2) despite the fact that considerable human and material
resources were allocated to HIV-care, the health care system was still able to accommodate a larger
number of patients attending general reproductive health care, and (3) the fact that the uptake of
reproductive health services increased markedly during the period of the ART/PMTCT scale-up suggests
that the rollout of HIV-care may have been an important driver behind the increased uptake.
The increases in service uptake happened without any identifiable decrease in quality of care. Maternal and
perinatal pregnancy outcomes were difficult to obtain for the entire study period, but the positive
outcomes of the 4M-study show that – at least between 2007 and 2009 – facility-based maternal
pregnancy outcomes improved significantly (van den Akker et al. 2011; van den Akker et al. 2009). This is an
important finding that contradicts, at least for Thyolo district, claims that fragile health systems in sub-












The tremendous increase in the uptake of ANC may have been the result of several factors, including: (1) 
increased health promotion efforts to all women, including HIV-positive women, (2) increased quality of 
antenatal care due to increased supervision, easy access to HIV testing and counselling, integrated PMTCT 
with a combined regimen, and (3) improved impression of health services in general, due to improvements 
in intrapartum care, increased availability of ART and increased availability of health staff (partly as a result 
of the staff clinic). The increase in women coming for at least four antenatal visits may have been due to an 
increase in the number of women coming for PMTCT-care who are urged to come every month for their 
ART or AZT-refills, although clinic records do not differentiate between PMTCT and non-PMTCT women 
among those coming for a fourth visit. The number of women coming for four or more antenatal visits 
before 2008 were not recorded. Increased health promotion and improvements in quality of care are also 
the likely contributors to the increased uptake of postpartum care, family planning services and STI 
treatment. 
It is important to note that the quality improvements described are measures that have been implemented 
at programme level. Whether these measures have actually raised quality in the eyes of people accessing 
care would require additional qualitative research. Semi-structured in-depth interviews and a focus group 
discussion conducted earlier among health workers in Thyolo showed that health staff were generally 
satisfied with the way obstetric audit sessions were conducted. Staff found audit a useful and satisfactory 
activity, particularly because of its educational value. Audit clearly had become part of the professional 
routine in this district hospital with limited availability of material and human resources (Bakker et al. 
2011). 
It is not clear why the number of women accessing STI treatment went down between 2008 and 2009. An 
optimistic interpretation would be that access to ART and health promotion messages given alongside 
supplementation of ART may have reduced the incidence of STIs. Available data, unfortunately, do not 











be that the reduction was due to several shortages of STI-drugs that occurred in 2009 due to logistical and 
financial problems within the government supply chain. 
An important explanation for the favourable outcomes described in this report lies in the fact that PMTCT 
and ART were delivered in an integrated manner, through the public health system, by health staff in the 
same clinics used for general health care. This means that HIV testing and counselling, PMTCT and ART care 
could be accessed by patients at the same place and time they received their general peripartum care. This 
will favourably affect losses to follow-up of those accessing PMTCT and ART and will, at the same time, 
improve the credibility of the general health services. The fact that PMTCT and ART are readily available 
should one be tested HIV-positive, could potentially have a positive effect on women’s decision to seek 
care. The fact that PMTCT and ART were provided at the general clinic also forced both MoH and MSF 
health managers to keep the general health system in mind while planning the scale-up, and increased 
effective and transparent joint governance of the health system. Initially, MSF brought in some extra 
human resources to facilitate the scaling up. Where these staff used to work independently from the rest of 
the system providing HIV-care only, they have recently been incorporated in the general system providing 
general peripartum care. These MSF service providers are gradually reduced. Even with these ‘external’ 
providers from outside the public health system, Thyolo had no more human resources in the health sector 
than any other district in Malawi in recent years. The central government is likely to have adjusted 
allocations of staff to Thyolo as a compensation mechanism for the presence of MSF.  
It is understandable that those concerned with the general health of women and children have grown 
apprehensive of the substantial resources devoted to HIV-care in many places. Similar investments were 
unlikely to have been made towards providing comprehensive maternal and child health care in the pre-
HIV era. In some places, it may appear that HIV/AIDS draws resources away from the public health sector. 
However, it may well be that the financial situation of the local public health sector would be in an even 
more deplorable state without the influx of HIV-money. Although the findings presented here are context-











may be beneficial, for the health of both HIV-positive and the HIV-negative women, to try and tackle 















During the period of ART/PMTCT scale-up in Thyolo District, uptake of antenatal, intrapartum and 
postpartum care, family planning services and STI treatment all increased significantly. Infrastructure 
available for reproductive health care improved, partly as a result of the influx of HIV funding. Although 
data for some indicators  were difficult to obtain, pregnancy outcomes appear to have improved during the 
period of scaling up HIV-services. The number of children born to mothers that received PMTCT services 
who tested HIV-positive at six weeks of age was low and, in addition, an independent study of maternal 
mortality and morbidity in Thyolo showed a reduction in severe maternal complications between 2007 and 
2009 after implementing systematic obstetric audit and feedback. The implementation of 
recommendations coming from audit was partly made possible by the availability of HIV-funding. Based on 
these findings, it can be concluded that ART/PMTCT scale-up in Thyolo has very likely contributed to the 
increased uptake of general reproductive health care, while the performance of the reproductive health 













1. Since ART and PMTCT rollout in high-prevalence HIV-countries may well be accompanied by other 
positive reproductive health outcomes, the scale-up should remain a public health priority for national 
governments, non-governmental actors and international donors. Concerns that the rollout would be 
detrimental to general reproductive health services in terms of uptake and outcome are understandable, 
but not necessarily justified. This study shows that, provided the general health system is taken into 
consideration while planning the scale-up, increased access to HIV care may also enhance the uptake of 
general reproductive health services without a negative effect on health outc mes. The question should 
not be whether to rollout but rather how to roll out. 
2. Weaknesses within the general health system should be considered during the rollout of ART and PMTCT 
and investments in HIV-services should also address these weaknesses within the general health system 
within which HIV-services are delivered. Underlying this recommendation is the understanding that 
sustainable HIV-care is not possible without a well-functioning system to deliver it. Investments towards 
strengthening  the general health care system will benefit both the ART/PMTCT scaling-up as well as uptake 
and quality of general health services, including reproductive health. The findings of this report indicate 
that investments in a district health system may produce significant improvements in reproductive health 
outcomes, provided they are well planned. 
3. Maternal mortality and HIV should be tackled together by the same interventions rather than separately. 
The ART rollout should be promoted as an essential element of primary maternal care and during the ART 
scale-up, pregnant women should be considered a priority group. ART will reduce MTCT, promote women’s 











4. More evidence is needed to demonstrate  the effects of scaled-up HIV care on general health services
and outcomes, especially within well-integrated HIV-programmes. Since it is difficult to generalize findings 
from Thyolo automatically to other settings, the findings of this report should encourage others who 
developed similar or different initiatives elsewhere to document and publish their experiences. 
5. The increased uptake of reproductive health services that would hopefully result in the improvement of
women’s health should form a basis for poor women in low-income countries and civil society groups
representing them to enhance advocacy for women’s right to health care. The barriers for poor young
women to acquire a joint political force are manifold, and those concerned with maternal and child health
should not consider their job done once basic care has been provided but encourage women to organize 
themselves and help them break down these barriers. In this way, uptake of health care and improvements
in quality of care should enhance women’s dignity and their chances to acquire a space within the political 
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